Trial Profile
Efficacy of tiotropium and indacaterol combination therapy to improve the airflow limitation in patients with moderate to very-severe chronic obstructive pulmonary disease (COPD)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 19 Aug 2015 New trial record